Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yumiko Kaku

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Expert Review of Anticancer Therapy|March 27, 2018
The diagnosis and management of extramammary Paget's diseaseTakamichi Ito, Yumiko Kaku-Ito, Masutaka Furue
Journal of Clinical Medicine|March 6, 2021
The Outcome of Chemotherapy for Metastatic Extramammary Paget's DiseaseHiroki Hashimoto, Yumiko Kaku-Ito, Masutaka Furue, et al.
Frontiers in Oncology|August 16, 2021
CDK4: A Novel Therapeutic Target for Extramammary Paget's DiseaseHiroki Hashimoto, Yumiko Kaku-Ito, Yoshinao Oda, et al.
Frontiers in Medicine|December 25, 2023
A real-world study on the safety profile of extended-interval dosing of immune checkpoint inhibitors for melanoma: a single-center analysis in JapanTakamichi Ito, Yumiko Kaku-Ito, Fumitaka Ohno, et al.
Frontiers in Oncology|May 3, 2021
Mucosal Invasion, but Not Incomplete Excision, Has Negative Impact on Long-Term Survival in Patients With Extramammary Paget's DiseaseHiroki Hashimoto, Yumiko Kaku-Ito, Masutaka Furue, et al.
Journal of Clinical Medicine|July 26, 2020
Narrow-Margin Excision for Invasive Acral Melanoma: Is It Acceptable?Takamichi Ito, Yumiko Kaku-Ito, Maiko Wada-Ohno, et al.
International Journal of Molecular Sciences|August 23, 2020
NECTIN4 Expression in Extramammary Paget's Disease: Implication of a New Therapeutic TargetMaho Murata, Takamichi Ito, Yuka Tanaka, et al.
Human Cell|July 11, 2023
KS-EMPD-1: a novel cell line of primary extramammary Paget's diseaseTakamichi Ito, Yuka Tanaka, Toshio Ichiki, et al.
Journal of Clinical Medicine|March 29, 2023
Nail Apparatus Melanoma: Current Management and Future PerspectivesTakamichi Ito, Hiroki Hashimoto, Yumiko Kaku-Ito, et al.
Scientific Reports|February 20, 2024
FOXM1: a new therapeutic target of extramammary Paget diseaseTakamichi Ito, Yuka Tanaka, Yumiko Kaku-Ito, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Expert Review of Anticancer Therapy|March 27, 2018
The diagnosis and management of extramammary Paget's diseaseTakamichi Ito, Yumiko Kaku-Ito, Masutaka Furue
Journal of Clinical Medicine|March 6, 2021
The Outcome of Chemotherapy for Metastatic Extramammary Paget's DiseaseHiroki Hashimoto, Yumiko Kaku-Ito, Masutaka Furue, et al.
Frontiers in Oncology|August 16, 2021
CDK4: A Novel Therapeutic Target for Extramammary Paget's DiseaseHiroki Hashimoto, Yumiko Kaku-Ito, Yoshinao Oda, et al.
Frontiers in Medicine|December 25, 2023
A real-world study on the safety profile of extended-interval dosing of immune checkpoint inhibitors for melanoma: a single-center analysis in JapanTakamichi Ito, Yumiko Kaku-Ito, Fumitaka Ohno, et al.
Frontiers in Oncology|May 3, 2021
Mucosal Invasion, but Not Incomplete Excision, Has Negative Impact on Long-Term Survival in Patients With Extramammary Paget's DiseaseHiroki Hashimoto, Yumiko Kaku-Ito, Masutaka Furue, et al.
Journal of Clinical Medicine|July 26, 2020
Narrow-Margin Excision for Invasive Acral Melanoma: Is It Acceptable?Takamichi Ito, Yumiko Kaku-Ito, Maiko Wada-Ohno, et al.
International Journal of Molecular Sciences|August 23, 2020
NECTIN4 Expression in Extramammary Paget's Disease: Implication of a New Therapeutic TargetMaho Murata, Takamichi Ito, Yuka Tanaka, et al.
Human Cell|July 11, 2023
KS-EMPD-1: a novel cell line of primary extramammary Paget's diseaseTakamichi Ito, Yuka Tanaka, Toshio Ichiki, et al.
Journal of Clinical Medicine|March 29, 2023
Nail Apparatus Melanoma: Current Management and Future PerspectivesTakamichi Ito, Hiroki Hashimoto, Yumiko Kaku-Ito, et al.
Scientific Reports|February 20, 2024
FOXM1: a new therapeutic target of extramammary Paget diseaseTakamichi Ito, Yuka Tanaka, Yumiko Kaku-Ito, et al.
Pageof 3